FDA Inspection 1043235 — Alturas Analytics, Inc
The FDA completed an inspection of Alturas Analytics, Inc on February 16, 2018 in Moscow, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Moscow, ID (United States)
Additional Details
Bioanalytical BA/BE